Among previously untreated adults with Gaucher disease type 1, a genetic disease in which there is improper metabolism due to a defect in an enzyme, treatment with the drug eliglustat resulted in significant improvements in liver and spleen size hemoglobin level, and platelet count, according to a new study.

Source: Drug improves measures of genetic disease that affects liver, spleen


David Cottle

UBB Owner & Administrator